Short-Term Dairy Elimination and Reintroduction Minimally Perturbs the Gut Microbiota in Self-Reported Lactose Intolerant Adults

One of the outstanding questions regarding the human gut microbiota is how interventions designed to manipulate the microbiota may influence host phenotypic traits. Here, we employed a dietary intervention to probe this question in the context of lactose intolerance. To assess the effects of dairy elimination and reintroduction on the microbiota and host phenotype, we paired fecal 16S rRNA amplicon sequencing with a clinical assay for lactose intolerance, the hydrogen breath test. We studied 12 self-reported mildly lactose intolerant adults, each with tri-weekly collection of fecal samples over a 12-week study period (2 weeks baseline, 4 weeks of dairy elimination, 6 weeks of gradual milk reintroduction) and a hydrogen breath test before and after each phase. We found that although none of the subjects experienced a change in clinically defined status of lactose intolerant or tolerant, most subjects were qualitatively better able to tolerate dairy products with minimal symptoms at the end of the study compared to their baseline. Like clinical status, gut microbiota also resisted modification. Although the mean fraction of the genus Bifidobacterium, a group known to metabolize lactose, increased slightly with dairy reintroduction (from 0.0125 to 0.0206; Wilcoxon P = 0.068), the overall structure of each subject's gut microbiota remained highly individualized and largely stable. Our study is small, but it suggests the possibility of qualitatively improved tolerance in the absence of change in clinically defined tolerance nor major change in the gut microbiota.

Download Full-text

Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study

Microorganisms ◽

10.3390/microorganisms9061237 ◽

2021 ◽

Vol 9 (6) ◽

pp. 1237

Author(s):

Han-Na Kim ◽

Eun-Jeong Joo ◽

Chil-Woo Lee ◽

Kwang-Sung Ahn ◽

Hyung-Lae Kim ◽

...

Keyword(s):

Gut Microbiota ◽

Gastrointestinal Symptoms ◽

Amplicon Sequencing ◽

Recovery Phase ◽

Fecal Samples ◽

Intestinal Microbes ◽

Gut Dysbiosis ◽

16S Rrna Amplicon Sequencing ◽

Microbiome Data ◽

Negative Conversion

Patients with COVID-19 have been reported to experience gastrointestinal symptoms as well as respiratory symptoms, but the effects of COVID-19 on the gut microbiota are poorly understood. We explored gut microbiome profiles associated with the respiratory infection of SARS-CoV-2 during the recovery phase in patients with asymptomatic or mild COVID-19. A longitudinal analysis was performed using the same patients to determine whether the gut microbiota changed after recovery from COVID-19. We applied 16S rRNA amplicon sequencing to analyze two paired fecal samples from 12 patients with asymptomatic or mild COVID-19. Fecal samples were selected at two time points: during SARS-CoV-2 infection (infected state) and after negative conversion of the viral RNA (recovered state). We also compared the microbiome data with those from 36 healthy controls. Microbial evenness of the recovered state was significantly increased compared with the infected state. SARS-CoV-2 infection induced the depletion of Bacteroidetes, while an abundance was observed with a tendency to rapidly reverse in the recovered state. The Firmicutes/Bacteroidetes ratio in the infected state was markedly higher than that in the recovered state. Gut dysbiosis was observed after infection even in patients with asymptomatic or mild COVID-19, while the composition of the gut microbiota was recovered after negative conversion of SARS-CoV-2 RNA. Modifying intestinal microbes in response to COVID-19 might be a useful therapeutic alternative.

Download Full-text

H. pylori Eradication Treatment Alters Gut Microbiota and GLP-1 Secretion in Humans

Journal of Clinical Medicine ◽

10.3390/jcm8040451 ◽

2019 ◽

Vol 8 (4) ◽

pp. 451 ◽

Cited By ~ 11

Author(s):

Isabel Cornejo-Pareja ◽

Gracia Martín-Núñez ◽

M. Roca-Rodríguez ◽

Fernando Cardona ◽

Leticia Coin-Aragüez ◽

...

Keyword(s):

Microbial Community ◽

Gut Microbiota ◽

Carbohydrate Metabolism ◽

Eradication Therapy ◽

Amplicon Sequencing ◽

Antibiotic Use ◽

Metabolic Disturbances ◽

Bifidobacterium Adolescentis ◽

16S Rrna Amplicon Sequencing ◽

H Pylori

Changes in the intestinal microbial community and some metabolic disturbances, including obesity and type2 diabetes, are related. Glucagon-like peptide-1 (GLP-1) regulates glucose homeostasis. Microbiota have been linked to incretin secretion. Antibiotic use causes changes in microbial diversity and composition. Our aim was to evaluate the relationship between microbiota changes and GLP-1 secretion. A prospective case-control study with a Helicobacter pylori-positive patient model involving subjects under eradication therapy (omeprazole, clarithromycin, and amoxicillin). Forty patients with H. pylori infection and 20 matched participants, but negative for H. pylori antigen. Patients were evaluated before and two months after treatment. We analyzed anthropometric measurements, carbohydrate metabolism, lipid profile, and C-reactive protein. Gut microbiota composition was analyzed through 16S rRNA amplicon sequencing (IlluminaMiSeq). Eradication treatment for H. pylori decreased bacterial richness (Chao1, p = 0.041). Changes in gut microbiota profiles were observed at phylum, family, genus and species levels. GLP-1 secretion and variables of carbohydrate metabolism were improved. Correlations were seen between GLP-1 changes and variations within microbial community abundances, specifically Bifidobacterium adolescentis, the Lachnobacterium genus, and Coriobacteriaceae family. A conventional treatment to eradicate H. pylori could improve carbohydrate metabolism possibly in relation with an increase in GLP-1 secretion. GLP-1 secretion may be related to alterations in intestinal microbiota, specifically Lachnobacterium, B. adolescentis and Coriobacteriaceae.

Download Full-text

Comparison of an increased waist circumference with a positive hydrogen breath test as a clinical predictor of lactose intolerance

Archivos Argentinos de Pediatria ◽

10.5546/aap.2017.eng.148 ◽

2017 ◽

Vol 115 (2) ◽

Keyword(s):

Waist Circumference ◽

Breath Test ◽

Lactose Intolerance ◽

Hydrogen Breath Test ◽

Clinical Predictor

Download Full-text

The Effect of Lactobacillus plantarum BW2013 on The Gut Microbiota in Mice Analyzed by 16S rRNA Amplicon Sequencing

Polish Journal of Microbiology ◽

10.33073/pjm-2021-022 ◽

2021 ◽

Vol 70 (2) ◽

pp. 235-243

Author(s):

TONG TONG ◽

XIAOHUI NIU ◽

QIAN LI ◽

YUXI LING ◽

ZUMING LI ◽

...

Keyword(s):

16S Rrna ◽

Gut Microbiota ◽

Dose Group ◽

Low Dose ◽

Amplicon Sequencing ◽

Control Group ◽

High Dose ◽

Treatment Groups ◽

16S Rrna Amplicon Sequencing ◽

Medium Dose

Lactobacillus plantarum BW2013 was isolated from the fermented Chinese cabbage. This study aimed to test the effect of this strain on the gut microbiota in BALB/c mice by 16S rRNA amplicon sequencing. The mice were randomly allocated to the control group and three treatment groups of L. plantarum BW2013 (a low-dose group of 108 CFU/ml, a medium-dose group of 109 CFU/ml, and a high-dose group of 1010 CFU/ml). The weight of mice was recorded once a week, and the fecal samples were collected for 16S rRNA amplicon sequencing after 28 days of continuous treatment. Compared with the control group, the body weight gain in the treatment groups was not significant. The 16S rRNA amplicon sequencing analysis showed that both the Chao1 and ACE indexes increased slightly in the medium-dose group compared to the control group, but the difference was not significant. Based on PCoA results, there was no significant difference in β diversity between the treatment groups. Compared to the control group, the abundance of Bacteroidetes increased in the low-dose group. The abundance of Firmicutes increased in the medium-dose group. At the genus level, the abundance of Alloprevotella increased in the low-dose group compared to the control group. The increased abundance of Ruminococcaceae and decreased abundance of Candidatus_Saccharimonas was observed in the medium-dose group. Additionally, the abundance of Bacteroides increased, and Alistipes and Candidatus_Saccharimonas decreased in the high-dose group. These results indicated that L. plantarum BW2013 could ameliorate gut microbiota composition, but its effects vary with the dose.

Download Full-text

Korean Traditional Medicine (Jakyakgamcho-tang) Ameliorates Colitis by Regulating Gut Microbiota

Metabolites ◽

10.3390/metabo9100226 ◽

2019 ◽

Vol 9 (10) ◽

pp. 226 ◽

Cited By ~ 1

Author(s):

Seung-Ho Seo ◽

Tatsuya Unno ◽

Seong-Eun Park ◽

Eun-Ju Kim ◽

Yu-Mi Lee ◽

...

Keyword(s):

Gut Microbiota ◽

Amplicon Sequencing ◽

Control Group ◽

Scaling Analysis ◽

Aminosalicylic Acid ◽

Operational Taxonomic Units ◽

16S Rrna Amplicon Sequencing ◽

Cytokine Levels ◽

Korean Traditional Medicine ◽

Gut Microbial Community

The objective of this study was to examine the anti-colitis activity of Jakyakgamcho-tang (JGT) in dextran sulfate sodium (DSS)-induced colitis and explore changes of the gut microbial community using 16S rRNA amplicon sequencing and metabolomics approaches. It was found that treatment with JGT or 5-aminosalicylic acid (5-ASA) alleviated the severity of colitis symptoms by suppressing inflammatory cytokine levels of IL-6, IL-12, and IFN-γ. The non-metric multidimensional scaling analysis of gut microbiome revealed that JGT groups were clearly separated from the DSS group, suggesting that JGT administration altered gut microbiota. The operational taxonomic units (OTUs) that were decreased by DSS but increased by JGT include Akkermansia and Allobaculum. On the other hand, OTUs that were increased by DSS but decreased by 5-ASA or JGT treatments include Bacteroidales S24-7, Ruminococcaceae, and Rikenellaceae, and the genera Bacteroides, Parabacteroides, Oscillospira, and Coprobacillus. After JGT administration, the metabolites, including most amino acids and lactic acid that were altered by colitis induction, became similar to those of the control group. This study demonstrates that JGT might have potential to effectively treat colitis by restoring dysbiosis of gut microbiota and host metabolites.

Download Full-text

Lactose intolerance, detected by the hydrogen breath test, in infants and children with chronic diarrhoea

Archives of Disease in Childhood ◽

10.1136/adc.52.10.766 ◽

1977 ◽

Vol 52 (10) ◽

pp. 766-771 ◽

Cited By ~ 35

Author(s):

H. V. L. Maffei ◽

G. Metz ◽

V. Bampoe ◽

M. Shiner ◽

S. Herman ◽

...

Keyword(s):

Breath Test ◽

Lactose Intolerance ◽

Infants And Children ◽

Chronic Diarrhoea ◽

Hydrogen Breath Test ◽

In Infants And Children

Download Full-text

Gut Microbiota Modulation by Dietary Barley Malt Melanoidins

Nutrients ◽

10.3390/nu12010241 ◽

2020 ◽

Vol 12 (1) ◽

pp. 241 ◽

Cited By ~ 1

Author(s):

Nesreen Aljahdali ◽

Pascale Gadonna-Widehem ◽

Pauline M. Anton ◽

Franck Carbonero

Keyword(s):

Fatty Acids ◽

Gut Microbiota ◽

Amplicon Sequencing ◽

Short Chain Fatty Acids ◽

Control Group ◽

Maillard Reaction Products ◽

Reaction Products ◽

Barley Malt ◽

16S Rrna Amplicon Sequencing ◽

The Impact

Melanoidins are the final Maillard reaction products (protein–carbohydrate complexes) produced in food by prolonged and intense heating. We assessed the impact of the consumption of melanoidins from barley malts on gut microbiota. Seventy-five mice were assigned into five groups, where the control group consumed a non-melanoidin malt diet, and other groups received melanoidin-rich malts in increments of 25% up to 100% melanoidin malts. Feces were sampled at days 0, 1, 2, 3, 7, 14, and 21 and the microbiota was determined using V4 bacterial 16S rRNA amplicon sequencing and short-chain fatty acids (SCFA) by gas chromatography. Increased melanoidins was found to result in significantly divergent gut microbiota profiles and supported sustained SCFA production. The relative abundance of Dorea, Oscillibacter, and Alisitpes were decreased, while Lactobacillus, Parasutterella, Akkermansia, Bifidobacterium, and Barnesiella increased. Bifidobacterium spp. and Akkermansia spp. were significantly increased in mice consuming the highest melanoidin amounts, suggesting remarkable prebiotic potential.

Download Full-text

Effect of low-iron micronutrient powder (MNP) on the composition of gut microbiota of Bangladeshi children in a high-iron groundwater setting: a randomized controlled trial

European Journal of Nutrition ◽

10.1007/s00394-021-02523-1 ◽

2021 ◽

Author(s):

Sabuktagin Rahman ◽

Guus A. M. Kortman ◽

Jos Boekhorst ◽

Patricia Lee ◽

Moududur R. Khan ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Gut Microbiota ◽

Treatment Effect ◽

Controlled Trial ◽

Amplicon Sequencing ◽

High Concentration ◽

Significant Treatment ◽

Randomized Controlled ◽

16S Rrna Amplicon Sequencing ◽

Micronutrient Powder

Abstract Purpose Adverse effects of iron fortification/supplements such as Micronutrient Powder (MNP) on gut microbiota have previously been found in infection-prone African settings. This study examined the adversaries of a low-iron MNP compared with the standard MNP on the composition of gut microbiota in Bangladeshi children exposed to a high concentration of iron from potable groundwater. Methods A randomized controlled trial was conducted in 2- to 5-year-old children, drinking groundwater with a high concentration of iron (≥ 2 mg/L). Children were randomized to receive one sachet per day of either standard MNP (12.5 mg iron) or low-iron MNP (5 mg iron), for 2 months. A sub-sample of 53 children was considered for paired assessment of the gut microbiome by 16S rRNA amplicon sequencing. Results At baseline, the gut microbiota consisted of Bifidobacteriaceae (15.6%), Prevotellaceae (12.2%), Lactobacillaceae (3.6%), Clostridiaceae (4.1%) and Enterobacteriaceae (2.8%). Overall, there was no significant treatment effect of the low-iron MNP compared to the standard MNP. However, an apparent treatment effect was observed in children with a relative adult-like microbiota, with a higher relative abundance of potentially pathogenic Enterobacteriaceae after receiving the standard MNP compared to the low-iron MNP. This effect, however, was statistically non-significant (p = 0.07). Conclusion In Bangladeshi children drinking iron-rich groundwater, a low-iron MNP supplementation did not have a significant impact on their gut microbiota profile/composition compared to the standard MNP. The trial registration number is ISRCTN60058115; Date of registration 03/07/2019; retrospectively registered.

Download Full-text

Lactose Intolerance Assessed by Analysis of Genetic Polymorphism, Breath Test and Symptoms in Patients with Inflammatory Bowel Disease

Nutrients ◽

10.3390/nu13041290 ◽

2021 ◽

Vol 13 (4) ◽

pp. 1290

Author(s):

Olga Maria Nardone ◽

Francesco Manfellotto ◽

Caterina D’Onofrio ◽

Alba Rocco ◽

Giovanni Annona ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Breath Test ◽

Lactose Intolerance ◽

Intermediate Phenotype ◽

Control Group ◽

Nucleotide Polymorphisms ◽

Wild Type ◽

Hydrogen Breath Test ◽

Inflammatory Bowel

Many patients with inflammatory bowel disease (IBD) restrict dairy products to control their symptoms. The aim of the study was to investigate the prevalence of lactose intolerance assessed with hydrogen breath test (H-BT) in IBD patients in clinical remission compared to a sex, age and BMI matched control population. We further detected the prevalence of three single nucleotide polymorphisms of the lactase (LCT) gene: the lactase non persistence LCT-13910 CC (wildtype) and the intermediate phenotype LCT-22018 CT and LCT-13910 AG; finally, we assess the correlation between genotype and H-BT. A total of 54 IBD patients and 69 control who underwent clinical evaluation, H-BT and genetic test were enrolled. H-BT was positive in 64.8% IBD patients and 62.3% control (p = 0.3). The wild-type genotype was found in 85.2% IBD patients while CT-22018, AG-13910 and CT-22018/AG-13910 polymorphisms were found in 9.3%, 1.8% and 3.7%. In the control group, the wild-type genotype, CT-22018, AG-13910 and CT-22018/AG-13910 polymorphisms were found in 87%, 5.8%, 5.8% and 1.4% of cases, respectively. Therefore, the wild-type and polymorphisms’ prevalence did not differ between IBD population and control group (85.2% vs. 87%, p = 0.1) (14.8% vs. 13%, p = 0.7). The correlation between positive H-BT and genetic analysis showed that the wild-type genotype was associated with higher rate of lactose intolerance in the total population (OR 5.31, 95%CI 1.73–16.29, p = 0.003) and in the IBD (OR 7.61, 95%CI 1.36–42.7, p = 0.02). The prevalence of lactose intolerance in IBD patients did not differ from that of control. Despite suggestive symptoms, about 1/3 of IBD patients are not lactose intolerant, thus not needing “a priori” elimination diet. This may encourage a rationale and balanced dietary management in IBD.

Download Full-text

On the robustness of inference of association with the gut microbiota in stool, swab and mucosal tissue samples

10.1101/2021.02.04.429844 ◽

2021 ◽

Author(s):

Shan Sun ◽

Xiangzhu Zhu ◽

Xiang Huang ◽

Harvey J. Murff ◽

Reid M. Ness ◽

...

Keyword(s):

Microbial Community ◽

Gut Microbiota ◽

Community Composition ◽

Microbial Community Composition ◽

Amplicon Sequencing ◽

Taxonomic Composition ◽

Mucosal Tissue ◽

Tissue Samples ◽

16S Rrna Amplicon Sequencing ◽

Functional Profiles

AbstractThe gut microbiota plays an important role in human health and disease. Stool, swab and mucosal tissue samples have been used in individual studies to survey the microbial community but the consequences of using these different sample types are not completely understood. We previously reported differences in microbial community composition with 16S rRNA amplicon sequencing between stool, swab and mucosal tissue samples. Here, we extended the previous study to a larger cohort and performed shotgun metagenome sequencing of 1,397 stool, swab and mucosal tissue samples from 240 participants. Consistent with previous results, taxonomic composition of stool and swab samples was distinct, but still more similar to each other than mucosal tissue samples, which had a substantially different community composition, characterized by a high relative abundance of the mucus metabolizers Bacteroides and Subdoligranulum, as well as bacteria with higher tolerance for oxidative stress such as Escherichia. As has been previously reported, functional profiles were more uniform across sample types than taxonomic profiles with differences between stool and swab samples smaller, but mucosal tissue samples remained distinct from the other two types. When the taxonomic and functional profiles of different sample types were used for inference in association with host phenotypes of age, sex, body mass index (BMI), antibiotics or non-steroidal anti-inflammatory drugs (NSAIDs) use, hypothesis testing using either stool or swab gave broadly similar results, but inference performed on mucosal tissue samples gave results that were generally less consistent with either stool or swab. Our study represents an important resource for the experimental design of studies aimed to understand microbiota perturbations specific to defined micro niches within the human intestinal tract.

Download Full-text